News and Events

Keep up-to-date on the latest media coverage and events for Intragel

Intragel announces its first head and neck cancer patient was treated with TumoCure injection, as part of its clinical trial phase 1b at Hadassah Medical Center in Israel

Intragel announces its first head and neck cancer patient was treated with TumoCure injection, as part of its clinical trial phase 1b at Hadassah Medical Center in Israel. 

Promising initial results showed the treatment was safe and tolerable with visual shrinkage of the tumor. 

If you are interested in joining our clinical trial please click here to learn more >> https://www.linkedin.com/feed/update/urn:li:activity:7024367 614462181377/